Published mark
Praxis Precision Medicines, Inc.
NASDAQ: PRAX. Canonical company identity and public leadership record.
US
Record source reportedRecord not claimedNo Eval published
- Alpha ID
- alpha:company:39b38c2f-a7f8-4324-b12a-4518f70a2ce6
- SEC CIK
- 0001689548
- Website
- www.praxismedicines.com Open
- Record version
- vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce, published Oct 15, 2026
- Newest evidence
- May 2, 2026
- Monitoring
- Not yet monitored Details
- Integrity
- Not yet signed Methodology
- CEO
- Marcio SouzaPresident, Chief Executive Officer & Director
- Chair
- Not published
- Independent
- 6 / 77 directors published
- Published claims
- 314 distinct sources
- Evidence records
- 110 pinned
- Source conflicts
- 0None open
Built from 4 distinct sources and 11 evidence records. Every Claim links to where it appears. Where nothing was published, the record states the coverage gap.
CorroboratedSource reportedAlpha inferenceNot disclosed
Public record. Alpha publishes governance facts about this organization from regulatory filings and company statements. Private enterprise overlay data is never projected here. The company can claim the record, correct, or dispute any Claim. How this works
EXECUTIVE APPOINTED
Alex Nemiroff executive of Praxis Precision Medicines, Inc., effective 2026-04-30.
EffectiveEffective Apr 30, 2026E3
Monitoring
ContinuousWhat the published record states about identity, evidence, evaluation, monitoring, authority, and freshness. Watched-source schedules are not published for this record.
- IdentityunclaimedPublished
- Evidencesource_reportedPublished
- Evaluationnot_evaluatedPublished
- MonitoringNot yet published for this record.Not published
- AuthorityNot yet published for this record.Not published
- FreshnesscurrentPublished
Leadership
Evidence| Role | Person | Since | Status | Claim |
|---|---|---|---|---|
| Named Executive Officer | Alex Nemiroff | Apr 2026 | current | Source reportedE3 |
| Chief Regulatory & Quality Officer | Alyssa J. S. Wyant | Not captured | unknown | Source reportedE4 |
| Chief Technical Operations Officer | Karl Hansen | Not captured | unknown | Source reportedE5 |
| Chief People Officer | Kelly McCue | Not captured | unknown | Source reportedE6 |
| President, Chief Executive Officer & Director | Marcio Souza | Not captured | unknown | Source reportedE7 |
| Chief Operating Officer | Megan T. Sniecinski | Not captured | unknown | Source reportedE8 |
| Co-Founder and President of Research & Development | Steven Petrou | Not captured | unknown | Source reportedE9 |
| Chief Financial Officer & Treasurer | Timothy Edwin Kelly | Not captured | unknown | Source reportedE10 |
Board of directors
Evidence7 directors published. 6 of 7 with a published determination are independent.
| Director | Status | Since | Committees | Claim |
|---|---|---|---|---|
| Dara F. Mitchell | Independent | 2020 | Compensation | Source reportedE2 |
| Gregory Norden | Independent | 2019 | Audit, chairAudit · Chair; CompensationCompensation | Source reportedE2 |
| Jeffrey Chodakewitz, M.D. | Independent | 2021 | None published | Source reportedE2 |
| Jill DeSimone | Independent | 2022 | AuditAudit; Compensation; Nominating and GovernanceCompensationNominating and Governance | Source reportedE2 |
| Marcio Souza | Not independent | 2020 | None published | Source reportedE2 |
| Merit Cudkowicz, M.D. | Independent | 2021 | None published | Source reportedE2 |
| William Young | Independent | 2016 | None published | Source reportedE2 |
| William Young | Independence not published | Not published | Compensation, chairNominating and Governance | Source reportedE11 |
Committees and risk ownership
Evidence| Committee | Chair | Members | Risks assigned |
|---|---|---|---|
| Audit | Gregory Norden | Gregory Norden, Jill DeSimone | Not described in the published record |
| Audit · Chair; Compensation | Not published | Gregory Norden | Not described in the published record |
| Audit; Compensation; Nominating and Governance | Not published | Jill DeSimone | Not described in the published record |
| Compensation | William Young | William Young, Dara F. Mitchell, Gregory Norden, Jill DeSimone | Not described in the published record |
| Nominating and Governance | Not published | Jill DeSimone, William Young | Not described in the published record |
Committee RecordAudit: Chair Gregory Norden; Members Gregory Norden (Chair); Jill DeSimone
Committee AppointmentGregory Norden: chair, Audit
Committee AppointmentJill DeSimone: member, Audit
Committee AppointmentWilliam Young: chair, Compensation
Committee AppointmentDara F. Mitchell: member, Compensation
Committee AppointmentGregory Norden: member, Compensation
Committee AppointmentJill DeSimone: member, Compensation
Committee RecordNominating and Governance: Chair not stated; Members Jill DeSimone; William Young
Committee AppointmentJill DeSimone: member, Nominating and Governance
Committee AppointmentWilliam Young: member, Nominating and Governance
Control and voting power
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Authority to act
Evidence and agent registryWho can act for the company, and on whose authority. This is what a counterparty's agent checks before it accepts an order, signs, or pays.
Principal executive officerMarcio Souza, President, Chief Executive Officer & Director
Who can authorize an agentNot assessedNo Alpha inference about signing authority or board-reserved matters is published for this record.
Not assessed
AI agents registered by the companyNot registered in the public RegistryAgent Deployments, Agent Use Cases, Authority Grants, TrustChecks, Action Ledger entries and Governance Receipts live in the private enterprise overlay. They are never projected into the public Registry without explicit cross-plane authorization. Absence here is a plane boundary, not evidence that the enterprise operates no agents.
Agent registry
Delegations publishedNot disclosedBoard and officer delegation resolutions are not public filings and are not published in this record.
Search scope
Financials and market context
EvidenceSecurity ListingPRAX (NASDAQ)
Index membershipsNo current membership is published in Alpha's tracked index universe.This is not evidence that the company is absent from every market index.
None publishedAs of Oct 16, 2026. Rights-filtered public evidence only; no redistribution or model training is granted. Only source-backed memberships with an explicit public redistribution basis are returned.
Governance and policies
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Risk, audit, and cyber
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
AI oversight and accountability
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Legal and regulatory
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Compensation
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Other published claims
EvidencePublished Claims that belong to no section above. Each keeps its permalink, evidence, and assertion state.
Legal NamePraxis Precision Medicines, Inc.
Entity StatusPublic listing published
Published FactUS
Published FactHealthcare
Not yet in this record
CoverageA gap is a coverage state, not a negative finding. These sections are expected for this entity class and are not yet published.
- Corporate structureNot reviewed. Parent, subsidiary and predecessor structure explains who is governed.
- OwnershipNot reviewed. Ownership and voting power determine who can influence the board.
- FinancialsNot reviewed. Governance-relevant financial context frames capital and audit decisions.
- CompensationNot reviewed. Pay design shows how incentives are governed.
- GovernanceNot reviewed. Governing documents and provisions set the rules of the enterprise.
- Shareholder governanceNot reviewed. Meeting and vote records show shareholder dissent and support.
- AuditNot reviewed. Auditor, controls and restatements show assurance over reporting.
- LegalNot reviewed. Material legal and regulatory matters show enforcement exposure.
- RiskNot reviewed. Risk ownership links the board, committees, executives and controls.
- CyberNot reviewed. Cyber and data governance is a disclosed oversight domain.
- AI governanceNot reviewed. AI oversight is a differentiated Alpha governance domain.
- Markets externalNot reviewed. Auditors, advisors, investors and regulators form the external ecosystem.
- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.This Company Profile is an identity and evidence record, not an Alpha rating.
Linked people
Same claims as person records- Alex NemiroffNamed Executive Officercompany:39b38c2f-a7f8-4324-b12a-4518f70a2ce6:leadership_role:14
- Alyssa J. S. WyantChief Regulatory & Quality Officercompany:39b38c2f-a7f8-4324-b12a-4518f70a2ce6:leadership_role:15
- Karl HansenChief Technical Operations Officercompany:39b38c2f-a7f8-4324-b12a-4518f70a2ce6:leadership_role:16
- Kelly McCueChief People Officercompany:39b38c2f-a7f8-4324-b12a-4518f70a2ce6:leadership_role:17
- Marcio SouzaPresident, Chief Executive Officer & Directorcompany:39b38c2f-a7f8-4324-b12a-4518f70a2ce6:leadership_role:18
- Megan T. SniecinskiChief Operating Officercompany:39b38c2f-a7f8-4324-b12a-4518f70a2ce6:leadership_role:19
- Steven PetrouCo-Founder and President of Research & Developmentcompany:39b38c2f-a7f8-4324-b12a-4518f70a2ce6:leadership_role:20
- Timothy Edwin KellyChief Financial Officer & Treasurercompany:39b38c2f-a7f8-4324-b12a-4518f70a2ce6:leadership_role:21
- Dara F. MitchellDirectorcompany:39b38c2f-a7f8-4324-b12a-4518f70a2ce6:leadership_role:7
- Gregory NordenDirectorcompany:39b38c2f-a7f8-4324-b12a-4518f70a2ce6:leadership_role:8
- Jeffrey Chodakewitz, M.D.Directorcompany:39b38c2f-a7f8-4324-b12a-4518f70a2ce6:leadership_role:9
- Jill DeSimoneDirectorcompany:39b38c2f-a7f8-4324-b12a-4518f70a2ce6:leadership_role:10
- Marcio SouzaDirectorcompany:39b38c2f-a7f8-4324-b12a-4518f70a2ce6:leadership_role:11
- Merit Cudkowicz, M.D.Directorcompany:39b38c2f-a7f8-4324-b12a-4518f70a2ce6:leadership_role:12
- William YoungDirectorcompany:39b38c2f-a7f8-4324-b12a-4518f70a2ce6:leadership_role:13
- William YoungDirector (committee appointment)company:39b38c2f-a7f8-4324-b12a-4518f70a2ce6:committee_record:25
Subject and corrections
Public-role doctrineThis record exists because the company is in the published Registry. The company can claim the record, correct, or dispute any Claim. Corrections are versioned and the original stays in history.
- Basis
- Published company record built from public sources
- Sources
- 11 evidence records cited. 0 with redistribution rights.
- Never published
- Private enterprise overlay data: deployments, authority grants, TrustChecks, receipts, telemetry
- Record claimed
- No
- Open disputes
- 0
- Identity ownership
- unclaimed
Claiming not yet available
If the company claims the record, its statements appear as their own assertion state and never overwrite the cited evidence.
Evidence
Authority and rights- E1Alpha canonical company public projection. canonical identity. Retrieved Oct 15, 2026. Cited by 5 Claims.
- E2sec proxy. Published Apr 30, 2025. Retrieved May 2, 2026. Cited by 7 Claims.
- E3sec filing. Published Apr 30, 2026. Retrieved May 9, 2026. Cited by 1 Claim.
- E4other. Published May 2, 2026. Retrieved May 2, 2026. Cited by 1 Claim.
- E5other. Published May 2, 2026. Retrieved May 2, 2026. Cited by 1 Claim.
- E6other. Published May 2, 2026. Retrieved May 2, 2026. Cited by 1 Claim.
- E7other. Published May 2, 2026. Retrieved May 2, 2026. Cited by 1 Claim.
- E8other. Published May 2, 2026. Retrieved May 2, 2026. Cited by 1 Claim.
- E9other. Published May 2, 2026. Retrieved May 2, 2026. Cited by 1 Claim.
- E10other. Published May 2, 2026. Retrieved May 2, 2026. Cited by 1 Claim.
- E11board_seats. board seats. Cited by 11 Claims.
What changed in version public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce
vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce published Oct 15, 2026- Alex Nemiroff executive of Praxis Precision Medicines, Inc., effective 2026-04-30.
- Jill DeSimone seat on Praxis Precision Medicines, Inc., effective 2022-01-01.
- Audit; Compensation; Nominating and Governance committee of Praxis Precision Medicines, Inc., effective 2022-01-01.
- Jill DeSimone member of Audit; Compensation; Nominating and Governance, effective 2022-01-01.
- Jeffrey Chodakewitz, M.D. seat on Praxis Precision Medicines, Inc., effective 2021-01-01.
- Merit Cudkowicz, M.D. seat on Praxis Precision Medicines, Inc., effective 2021-01-01.
- Dara F. Mitchell seat on Praxis Precision Medicines, Inc., effective 2020-01-01.
- Marcio Souza seat on Praxis Precision Medicines, Inc., effective 2020-01-01.
- Dara F. Mitchell member of Compensation, effective 2020-01-01.
- Gregory Norden seat on Praxis Precision Medicines, Inc., effective 2019-01-01.
- Audit · Chair; Compensation committee of Praxis Precision Medicines, Inc., effective 2019-01-01.
- Gregory Norden member of Audit · Chair; Compensation, effective 2019-01-01.
- William Young seat on Praxis Precision Medicines, Inc., effective 2016-01-01.